Pneumocystis Pneumonia

Lymphopenia and Steroids Increase the Risk of Pneumocystis Jiroveci in Systemic Rheumatic Diseases

It is well-known that patients with systemic autoimmune diseases are at risk for Pneumocystis jirovecii pneumonia (PJP) and although infrequent, it carries a high mortality. A new study shows lymphopenia and steroid use increases the risk of PJP.

Prophylaxis prevents PCP in rheumatic disease patients

Prophylaxis for steroid-associated pneumonia is a winner in patients with rheumatic diseases.